The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ekusheva E.V.

Academy of Postgraduate Education under the Federal State Budgetary Unit «Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency»;
Belgorod State National Research University

Biryukova E.V.

Evdokimov Moscow State University of Medicine and Dentistry

The efficacy of ethylmethylhydroxypyridine succinate in patients with cerebrovascular pathology complicated with diabetes mellitus and metabolic syndrome

Authors:

Ekusheva E.V., Biryukova E.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12): 138‑143

DOI: 10.17116/jnevro2020120121138

Read: 2634 times

Download PDF (RU)
Contact the author
Table of contents

THE EFFICACY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY COMPLICATED WITH DIABETES MELLITUS AND METABOLIC SYNDROME
THE EFFICACY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY COMPLICATED WITH DIABETES MELLITUS AND METABOLIC SYNDROME

To cite this article:

Ekusheva EV, Biryukova EV. The efficacy of ethylmethylhydroxypyridine succinate in patients with cerebrovascular pathology complicated with diabetes mellitus and metabolic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12):138‑143. (In Russ.)
https://doi.org/10.17116/jnevro2020120121138

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern approaches to diagnosis and treatment of postinfectious asthenic syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):42-52
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Prevalence of meta­bolic syndrome among the indi­genous popu­lation in central Yaku­tia rural areas. Russian Journal of Preventive Medi­cine. 2025;(5):21-26
Effi­ciency of anthropometric surrogate indi­ces for the meta­bolic syndrome and its components diagnosing in middle-aged Moscow men. Russian Journal of Preventive Medi­cine. 2025;(5):41-48
Features of comprehensive treatment in a patient with complicated type 2 diabetes mellitus: A clinical case. Piro­gov Russian Journal of Surgery. 2025;(6):128-132
Drinking mine­ral water for progressive resi­stance to insu­lin. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):24-30
Hype­rtensive diso­rders of pregnancy as a risk factor for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(6):114-119
Abstract:

Arterial hypertension, diabetes mellitus, obesity and dyslipidemia continue to be the main risk factors for diseases of the circulatory system and the leading causes of mortality in the world, the combination of these diseases significantly increases the likelihood of the development and more rapid progression of cardiovascular and cerebrovascular pathology. Improving approaches to the diagnosis and treatment of these diseases is a priority problem in modern medicine. Currently, there is no universal drug that can influence all stages of pathological process in both cerebrovascular diseases and diabetes mellitus, and the problem of rational use of drugs in patients with comorbid pathology has not been completely resolved. A difficult clinical task includes not only the timely detection of the disease and the correct diagnosis, but also the choice of the safest and most effective medicine. A number of clinical studies have demonstrated the efficacy of mexidol in the treatment of this category of patients, which is determined by its complex, pleiotropic and multimodal mechanisms of action.

Keywords:

cerebrovascular diseases
diabetes mellitus
metabolic syndrome
antioxidant therapy
mexidol

Authors:

Ekusheva E.V.

Academy of Postgraduate Education under the Federal State Budgetary Unit «Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency»;
Belgorod State National Research University

Biryukova E.V.

Evdokimov Moscow State University of Medicine and Dentistry

Received:

23.11.2020

Accepted:

25.11.2020

Close metadata

References:

  1. Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes. 1988;37(12):1595-1607. https://doi.org/10.2337/diab.37.12.1595
  2. Belenkov UN, Privalova EV, Kaplunova VU, et al. Metabolic syndrome: development of the issue, main diagnostic criteria. Racional’naya Farmakoterapiya v Kardiologii. 2018;14(5):757-764. (In Russ.). https://doi.org/10.20996/1819-6446-2018-14-5-757-764
  3. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37(3):806-811.  https://doi.org/10.1161/01.STR.0000204354.06965.44
  4. McNeil AM, Schmidt MI, Rosamond WD, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28(2):385-390.  https://doi.org/10.2337/diacare.28.2.385
  5. Tiehuis AM, Graaf Y, Mali WPTM, et al. Metabolic syndrome, prediabetes, and brain abnormalities on MRI in patients with manifest arterial disease: the SMART-MR study. Diabetes Care. 2014;37(9):2515-2521. https://doi.org/10.2337/dc14-0154
  6. Scharf EL, Graff-Radford J, Przybelski SA, et al. Cardiometabolic health and longitudinal progression of white matter hyperintensity: the Mayo clinic study of aging. Stroke. 2019;50(11):3037-3044. https://doi.org/10.1161/STROKEAHA.119.025822
  7. Schneider ALC, Selvin E, Sharrett AR, et . Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). Diabetes Care. 2017;40(11):1514-1521. https://doi.org/10.2337/dc17-1185
  8. Ekusheva EV. Elderly patient with comorbid pathology in the practice of a cardiologist. Russkij Medicinskij Zhurnal. 2018;2(11):26-29. (In Russ.).
  9. Stakhovskaya LV, Shamalov NA, Khasanova DR, et al. Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA). S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(3-2):55-65. (In Russ.). https://doi.org/10.17116/jnevro20171173255-65
  10. Khazanov VA. Pharmacologycal regulation of energy metabolizm. Eksperimental’naya i klinicheskaya farmakologiya. 2009;(4):61-64. (In Russ.).
  11. Bhogal RH, Curbishley SM, Weston CJ. R Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transplantation. 2010;16:1303-1313. https://doi.org/10.1002/lt.22157
  12. Damulin IV, Ekusheva EV. Recovery after stroke and process of neuroplasticity. Medicinskij Sovet. 2014;(18):12-19. (In Russ.). https://doi.org/10.21518/2079-701X-2014-18-12-19
  13. Sologub TV, Romantsov MG, Tokin II. The use of metadoxin in the complex therapy of chronic hepatitis C. Klinicist. 2010;(1):74-78. (In Russ.).
  14. Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;(11):21-26. (In Russ.). https://doi.org/10.1007/s11055-014-9891-8
  15. Mester NV. The effect of 3-hydroxypyridine derivatites on cognitive functions and affective status in patients with diabetes mellitus. Chelyabinsk. 2007. (In Russ.).
  16. Medvedeva LA, Gnezdilov AV, Zagorul’ko OI, et al. Neurometabolic therapy of diabetic neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2006;(7):75-77. (In Russ.).
  17. Zanozina OV, Borovkov NN, Balabolkin MI, et al. The use of antioxidants in the rational therapy of type 2 diabetes. Farmateka. 2006;(11):1-4. (In Russ.).
  18. Beliaev AN, Rygin EA, Zakhvatov AN, et al. Systemic and regional antioxidant therapy for complicated forms of diabetic foot. Hirurgiya. 2007;(11):46-50. (In Russ.).
  19. Volchegorskiy IA, Moskvicheva MG, Chashchina EN. Influence of the drug Mexidol on the manifestations of distal symmetric polyneuropathy in patients with diabetes mellitus foot syndrome. Farmateka. 2007;(11):76-79. (In Russ.).
  20. Statsenko ME, Turkina SV, Kosivtseva MA. Additional advantages of mexicor used in combined therapy of coronary heart disease and diabetes mellitus of 2nd type. Klinicheskaya Medicina. 2013;91(5):59-64. (In Russ.).
  21. Statsenko ME, Evtereva ED, Turkina SV, et al. New potential of mexicor in the treatment of chronic heart failure among patients with metabolic syndrome. Rossijskij Kardiologicheskij Zhurnal. 2010;(6):28-33. (In Russ.).
  22. Efimova TE. The use of mexicor in the complex treatment of patients with type 2 diabetes mellitus with vascular lesions of the lower extremities. Poliklinika. 2007;(2):34-37. (In Russ.).
  23. Ercan N, Nuttall FQ, Gannon MC, et al. Effects of glucose, galactose, and lactose ingestion on the plasma glucose and insulin response in persons with non-insulin-dependent diabetes mellitus. Metabolism. 1993;42(12):1560-1567. https://doi.org/10.1016/0026-0495(93)90151-d
  24. Aro A, Pelkonen R, Leino U. Glucose and insulin responses to meals containing milk, lactose, glucose or fructose in subjects with non-insulin-dependent diabetes. Diabete Metab. 1987;13(6):603-606. 
  25. Gannon MC, Nuttall FQ. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond). 2006;3:16.  https://doi.org/10.1186/1743-7075-3-16
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.